NYSE:USPH (USA) Also trade in: Germany

US Physical Therapy Inc

$ 126.58 0.78 (0.62%)
Volume: 4,762 Avg Vol (1m): 91,727
Market Cap $: 1.60 Bil Enterprise Value $: 1.61 Bil
P/E (TTM): 87.53 P/B: 7.20
Earnings Power Value 34.16
Net Current Asset Value -17.48
Tangible Book -9.58
Projected FCF 59.95
Median P/S Value 53.14
Graham Number 0
Peter Lynch Value 10.93
DCF (FCF Based) 61.68
DCF (Earnings Based) 15.3
1Y (-%)

Financial Strength : 7.2/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 0.66
Cash-To-Debt range over the past 10 years
Min: 0.17, Med: 0.68, Max: 10000
Current: 0.66
0.17
10000
Equity-to-Asset 0.42
Equity-to-Asset range over the past 10 years
Min: 0.27, Med: 0.65, Max: 0.97
Current: 0.42
0.27
0.97
Debt-to-Equity 0.14
Debt-to-Equity range over the past 10 years
Min: 0, Med: 0.23, Max: 2.18
Current: 0.14
0
2.18
Debt-to-EBITDA 0.41
Debt-to-EBITDA range over the past 10 years
Min: 0.04, Med: 0.63, Max: 0.94
Current: 0.41
0.04
0.94
Interest Coverage 33.94
Interest Coverage range over the past 10 years
Min: 2.6, Med: 46.45, Max: 140.64
Current: 33.94
2.6
140.64
Piotroski F-Score 7
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 4.95
DISTRESS
GREY
SAFE
Beneish M-Score -2.72
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 21.49%
WACC 9.65%

Profitability & Growth : 8/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % 13.57
Operating Margin range over the past 10 years
Min: 13.22, Med: 14.16, Max: 15.71
Current: 13.57
13.22
15.71
Net Margin % 7.84
Net Margin range over the past 10 years
Min: 4.82, Med: 6.25, Max: 9.06
Current: 7.84
4.82
9.06
ROE % 8.55
ROE range over the past 10 years
Min: 7.89, Med: 13.46, Max: 19.88
Current: 8.55
7.89
19.88
ROA % 7.94
ROA range over the past 10 years
Min: 5.78, Med: 8.13, Max: 13.79
Current: 7.94
5.78
13.79
ROC (Joel Greenblatt) % 232.73
ROC (Joel Greenblatt) range over the past 10 years
Min: 96.79, Med: 124.13, Max: 232.73
Current: 232.73
96.79
232.73
3-Year Total Revenue Growth Rate 11.10
3-Year Revenue Growth Rate range over the past 10 years
Min: 7.1, Med: 12.7, Max: 181.8
Current: 10.3
7.1
181.8
3-Year Total EBITDA Growth Rate 9.20
3-Year EBITDA Growth Rate range over the past 10 years
Min: 0, Med: 8.2, Max: 30.9
Current: 8.4
0
30.9
3-Year EPS w/o NRI Growth Rate -7.60
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: 0, Med: 7.6, Max: 127.6
Current: -7.6
0
127.6

» USPH's 30-Y Financials

Financials (Next Earnings Date: 2019-08-08)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NYSE:USPH

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Health Care Providers » Health Care Providers    NAICS : 621498    SIC : 8093
Compare TSE:7716 BKK:SVH-F JSE:NTC BOM:532843 SGX:BSL SZSE:000950 OTCPK:BLSTF BKK:BCH OHEL:TTALO ASX:HLS BKK:RAM-F SGX:A50 ISX:MIKA XTER:RHK KUW:MIDAN XSWX:AEVS NYSE:THC NAS:ADUS SAU:4004 NYSE:SEM
Traded in other countries UPH.Germany
Address 1300 West Sam Houston Parkway South, Suite 300, Houston, TX, USA, 77042
US Physical Therapy Inc operates outpatient physical therapy and occupational therapy clinics throughout the United States. Its clinics provide treatment for orthopedic disorders, sports-related injuries, and work-related injuries. The company also administers care designed to prevent injuries from occurring. At the start of 2002, the company operated 170 clinics in more than 30 states.

Ratios

Current vs industry vs history
PE Ratio (TTM) 87.53
PE Ratio range over the past 10 years
Min: 8.91, Med: 25.34, Max: 89.99
Current: 87.53
8.91
89.99
Forward PE Ratio 44.05
N/A
PE Ratio without NRI 87.53
PE without NRI range over the past 10 years
Min: 8.91, Med: 22.82, Max: 89.99
Current: 87.53
8.91
89.99
Price-to-Owner-Earnings 39.61
Price-to-Owner-Earnings range over the past 10 years
Min: 5.5, Med: 20.49, Max: 40.73
Current: 39.61
5.5
40.73
PB Ratio 7.20
PB Ratio range over the past 10 years
Min: 1.12, Med: 3.07, Max: 7.69
Current: 7.2
1.12
7.69
PS Ratio 3.46
PS Ratio range over the past 10 years
Min: 0.49, Med: 1.46, Max: 3.64
Current: 3.46
0.49
3.64
Price-to-Free-Cash-Flow 25.33
Price-to-Free-Cash-Flow range over the past 10 years
Min: 3.33, Med: 10.48, Max: 27.32
Current: 25.33
3.33
27.32
Price-to-Operating-Cash-Flow 22.36
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 2.83, Med: 9.36, Max: 24.32
Current: 22.36
2.83
24.32
EV-to-EBIT 24.91
EV-to-EBIT range over the past 10 years
Min: 3.9, Med: 11.2, Max: 28.5
Current: 24.91
3.9
28.5
EV-to-EBITDA 21.69
EV-to-EBITDA range over the past 10 years
Min: 3.1, Med: 9.9, Max: 24.3
Current: 21.69
3.1
24.3
EV-to-Revenue 3.50
EV-to-Revenue range over the past 10 years
Min: 0.5, Med: 1.7, Max: 3.7
Current: 3.5
0.5
3.7
PEG Ratio 10.70
PEG Ratio range over the past 10 years
Min: 0.83, Med: 3.14, Max: 11.48
Current: 10.7
0.83
11.48
Shiller PE Ratio 77.21
Shiller PE Ratio range over the past 10 years
Min: 12.56, Med: 29.92, Max: 81.33
Current: 77.21
12.56
81.33
Current Ratio 1.18
Current Ratio range over the past 10 years
Min: 1.18, Med: 4.4, Max: 42
Current: 1.18
1.18
42
Quick Ratio 1.18
Quick Ratio range over the past 10 years
Min: 1.18, Med: 4.4, Max: 42
Current: 1.18
1.18
42
Days Sales Outstanding 38.29
Days Sales Outstanding range over the past 10 years
Min: 35.99, Med: 41.85, Max: 47.21
Current: 38.29
35.99
47.21
Days Payable 1.94
Days Payable range over the past 10 years
Min: 1.94, Med: 2.88, Max: 3.76
Current: 1.94
1.94
3.76

Dividend & Buy Back

Current vs industry vs history
Dividend Yield % 0.79
Trailing Dividend Yield range over the past 10 years
Min: 0.31, Med: 1.17, Max: 1.74
Current: 0.79
0.31
1.74
Dividend Payout Ratio 0.67
Dividend Payout Ratio range over the past 10 years
Min: 0.2, Med: 0.33, Max: 0.7
Current: 0.67
0.2
0.7
3-Year Dividend Growth Rate (Per Share) 15.30
3-Year Dividend Growth Rate range over the past 10 years
Min: 0, Med: 0, Max: 19.3
Current: 15.3
0
19.3
Forward Dividend Yield % 0.95
N/A
Yield-on-Cost (5-Year) % 1.84
Yield-on-Cost (5y) range over the past 10 years
Min: 0.71, Med: 2.69, Max: 4
Current: 1.84
0.71
4
3-Year Share Buyback Rate -0.70
3-Year Share Buyback Rate range over the past 10 years
Min: -9.8, Med: -0.9, Max: 7.7
Current: -0.7
-9.8
7.7

Valuation & Return

Current vs industry vs history
Price-to-Projected-FCF 2.09
Price-to-Intrinsic-Value-Projected-FCF range over the past 10 years
Min: 0.39, Med: 1.02, Max: 9.21
Current: 2.09
0.39
9.21
Price-to-DCF (Earnings Based) 8.18
Price-to-Intrinsic-Value-DCF (Earnings Based) range over the past 10 years
Min: 0.4, Med: 1.05, Max: 7.3
Current: 8.18
0.4
7.3
Price-to-Median-PS-Value 2.36
Price-to-Median-PS-Value range over the past 10 years
Min: 0.42, Med: 1, Max: 14.08
Current: 2.36
0.42
14.08
Price-to-Peter-Lynch-Fair-Value 11.45
Price-to-Peter-Lynch-Fair-Value range over the past 10 years
Min: 0.47, Med: 1.71, Max: 11.77
Current: 11.45
0.47
11.77
Earnings Yield (Joel Greenblatt) % 4.02
Earnings Yield (Greenblatt) range over the past 10 years
Min: 3.5, Med: 8.9, Max: 25.9
Current: 4.02
3.5
25.9
Forward Rate of Return (Yacktman) % 10.51
Forward Rate of Return range over the past 10 years
Min: 10.5, Med: 15.2, Max: 26.9
Current: 10.51
10.5
26.9

More Statistics

Revenue (TTM) (Mil) $ 461.8
EPS (TTM) $ 1.43
Beta 1.3
Volatility % 34.67
52-Week Range $ 98.69 - 129.65
Shares Outstanding (Mil) 12.76

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 7
Positive ROA Y
Positive CFROA Y
Higher ROA yoy Y
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy N
Less Shares Outstanding yoy N
Higher Gross Margin yoy Y
Higher Asset Turnover yoy Y